GMO-produced vitamin B2
The problem
Riboflavin (Vitamin B2) is an essential micronutrient for non-ruminant animals (poultry, pigs) that must be supplemented. However, most industrial vitamin B2 is produced using genetically modified microorganisms, which is excluded by European organic legislation. This has historically led to an insecure supply situation and temporary exemptions from GMO-freeness. While GMO-free alternatives exist, a common EU decision on the legal status of some (feed vs. feed additive) remains unclear, hindering transparency and broader adoption.
What SCALE-it does
SCALE-it addresses this by compiling knowledge on the biological, economic, political, and societal implications of GMO-free vitamin B2. We initiate an interdisciplinary stakeholder information and decision process, including workshops, to facilitate the replacement of GMO-produced vitamin B2 with existing or newly developed GMO-free products. The goal is to clarify ambiguities, foster consensus, and ensure resilient access to GMO-free alternatives.
Expected results
The project aims to achieve clearer transparency in the legislative and factual use practice of GMO-free riboflavin within Europe. This involves progressing the status clarification of currently available GMO-free products. The ultimate goal is to facilitate the unambiguous declaration of non-GMO riboflavin use in all European organic feeds, thereby eliminating the perceived need for veterinary exemptions from GMO-freeness.
Latest news:
New SCALE-it scientific publication explores how a sustainable fungicide acts against major plant pathogens
Voices of SCALE-it: Advancing Biocontrol for Plant Health
Two EU Projects join forces to redefine organic farming
SCALE-it presented at the “Biocontrol in organic: managing plant health with complementary practices” event at the EU Parliament
SCALE-it holds its first Annual General Meeting in Granada
